Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Pham Quang X. Director active across 1 company, notably Cadrenal Therapeutics, Inc.. Cumulatively, 34 filings have been logged. Breakdown: 2 buys · 29 sells. Total volume traded: €263k. History available since 10 February 2023. The latest transaction was disclosed on 5 June 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pham Quang X
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Pham Quang X is a declarant associated with Cadrenal Therapeutics, Inc., where he serves as Chairman and CEO. He has made a total of 29 filings, all sampled, with a total buy amount of 25,561 EUR and a total sell amount of 128,169 EUR. The first filing date is February 13, 2023, and the last filing date is July 1, 2026. Among his recent filings, he sold 45,148.65 EUR on February 13, 2023, and bought 16,967.86 EUR on September 6, 2023.